In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Dallas and Phoenix labs. The ability to test healthcare partner samples at any one of the three labs is a critical element in creating the reliability the CTS healthcare partners desire so they can provide the blood that saves patients’ lives.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...